INLYTA (U.S. Pharmaceuticals)
Welcome to the PulseAid listing for the INLYTA drug offered from U.S. Pharmaceuticals. This Kinase Inhibitor [EPC],Receptor Tyrosine Kinase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | U.S. Pharmaceuticals |
NON-PROPRIETARY NAME: | axitinib |
SUBSTANCE NAME: | AXITINIB |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Kinase Inhibitor [EPC],Receptor Tyrosine Kinase Inhibitors [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, FILM COATED |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2012-01-27 |
END MARKETING DATE: | 0000-00-00 |
INLYTA HUMAN PRESCRIPTION DRUG Details:
Item Description | INLYTA from U.S. Pharmaceuticals |
LABELER NAME: | U.S. Pharmaceuticals |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 1(mg/1) |
START MARKETING DATE: | 2012-01-27 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 63539-026_52b7daa9-f0b6-493f-91c3-c204842c43e0 |
PRODUCT NDC: | 63539-026 |
APPLICATION NUMBER: | NDA202324 |
Other AXITINIB Pharmaceutical Manufacturers / Labelers: